Stockscreener 앱 받기
8.43
1.93%
0.16
시장 영업 전:
8.50
0.07
+0.83%
전일 마감가:
$8.27
열려 있는:
$8.21
하루 거래량:
6.07M
Relative Volume:
0.71
시가총액:
$2.89B
수익:
-
순이익/손실:
$-75.80M
주가수익비율:
-24.09
EPS:
-0.35
순현금흐름:
$-68.07M
1주 성능:
-1.40%
1개월 성능:
+70.99%
6개월 성능:
+365.75%
1년 성능:
+220.53%
1일 변동 폭
$8.00
$8.55
1주일 범위
$7.80
$8.9524
52주 변동 폭
$1.54
$8.9524
Nuvation Bio Inc Stock (NUVB) Company Profile
명칭
Nuvation Bio Inc
전화
(415) 754-3517
주소
357 TEHAMA STREET, FLOOR 3, SAN FRANCISCO
NUVB을(를) 다른 주식과 비교
| 주식 | 가격 | 시가총액 | 매출 | 순이익 | 현금흐름 | 주당 순 이익 |
|---|---|---|---|---|---|---|
NUVB
Nuvation Bio Inc
|
8.43 | 2.84B | 0 | -75.80M | -68.07M | -0.35 |
|
VRTX
Vertex Pharmaceuticals Inc
|
452.04 | 113.14B | 11.74B | 3.68B | 3.34B | 14.19 |
|
REGN
Regeneron Pharmaceuticals Inc
|
741.29 | 78.49B | 14.25B | 4.58B | 3.88B | 41.77 |
|
ARGX
Argen X Se Adr
|
877.94 | 54.76B | 3.06B | 1.28B | 447.35M | 19.67 |
|
ALNY
Alnylam Pharmaceuticals Inc
|
397.55 | 54.51B | 3.21B | 43.57M | 221.36M | 0.2405 |
|
INSM
Insmed Inc
|
197.01 | 41.64B | 447.02M | -1.18B | -906.14M | -6.1812 |
Nuvation Bio Inc Stock (NUVB) Upgrades & Downgrades
| 날짜 | 액션 | 분석자 | 등급 변경 |
|---|---|---|---|
| 2025-11-24 | 개시 | Truist | Buy |
| 2025-11-19 | 개시 | B. Riley Securities | Buy |
| 2025-09-30 | 개시 | Jefferies | Buy |
| 2025-04-23 | 개시 | Citizens JMP | Mkt Outperform |
| 2024-03-27 | 업그레이드 | Jefferies | Hold → Buy |
| 2024-03-26 | 업그레이드 | BTIG Research | Neutral → Buy |
| 2023-01-06 | 다운그레이드 | Jefferies | Buy → Hold |
| 2022-08-02 | 다운그레이드 | BMO Capital Markets | Outperform → Market Perform |
| 2022-08-02 | 다운그레이드 | BTIG Research | Buy → Neutral |
| 2022-05-04 | 개시 | H.C. Wainwright | Buy |
| 2021-10-15 | 재개 | BTIG Research | Buy |
| 2021-04-06 | 개시 | RBC Capital Mkts | Outperform |
| 2021-03-08 | 개시 | BMO Capital Markets | Outperform |
| 2021-03-08 | 개시 | BTIG Research | Buy |
| 2021-03-08 | 개시 | Cowen | Outperform |
| 2021-03-08 | 개시 | Jefferies | Buy |
| 2021-03-08 | 개시 | Wedbush | Outperform |
모두보기
Nuvation Bio Inc 주식(NUVB)의 최신 뉴스
Gap Down: How Nuvation Bio Inc stock reacts to oil prices2025 EndofYear Setup & High Conviction Buy Zone Picks - moha.gov.vn
Nuvation Bio Inc. $NUVB Shares Sold by OCONNOR A Distinct Business Unit of UBS ASSET MANAGEMENT AMERICAS LLC - MarketBeat
Natixis Buys Shares of 905,500 Nuvation Bio Inc. $NUVB - MarketBeat
Breakout Move: Why Nuvation Bio Inc stock is trending among retail tradersFed Meeting & Free Fast Entry Momentum Trade Alerts - moha.gov.vn
Nuvation Bio (NUVB) Soars After $18 Price-Target Hike – Is This High‑Growth Cancer Stock Still a Buy in 2025? - ts2.tech
Nuvation Bio (NYSE:NUVB) Shares Gap Up After Analyst Upgrade - MarketBeat
Nuvation Bio Stock Surges Amid Price Target Boost - TipRanks
HC Wainwright Issues Positive Forecast for Nuvation Bio (NYSE:NUVB) Stock Price - MarketBeat
Nuvation Bio stock price target raised to $18 from $10 at H.C. Wainwright By Investing.com - Investing.com South Africa
Nuvation Bio stock price target raised to $18 from $10 at H.C. Wainwright - Investing.com Nigeria
HC Wainwright & Co. Maintains Nuvation Bio (NUVB) Buy Recommendation - Nasdaq
Nuvation Bio (NUVB): Reassessing Valuation After Safusidenib Data and Taletrectinib China Reimbursement News - Sahm
Nuvation Bio (NYSE:NUVB) Trading Down 5.9%Here's Why - MarketBeat
Nuvation Bio Inc. $NUVB is Omega Fund Management LLC's 4th Largest Position - MarketBeat
Nuvation Bio (NUVB) price target increased by 12.48% to 10.65 - MSN
Nuvation Bio (NYSE: NUVB) partner taletrectinib added to China's 2025 NRDL - Stock Titan
Nuvation Bio (NUVB) Price Target Increased by 12.48% to 10.65 - Nasdaq
Tema Etfs LLC Purchases Shares of 139,648 Nuvation Bio Inc. $NUVB - MarketBeat
Nuvation Bio Stock Jump Looks Great, But How Secure Is That Gain? - Trefis
Nuvation Bio (NUVB) bounces back 12% on impressive clinical trial result - MSN
Why Nuvation Bio Inc. Class stock is a strong analyst pickPortfolio Update Report & Verified Momentum Stock Alerts - Newser
Cash per share of Nuvation Bio Inc. – NYSE:NUVB - TradingView
Will Nuvation Bio Inc. Warrants stock profit from AI boom2025 Risk Factors & Technical Buy Zone Confirmations - Newser
Insider Selling: Nuvation Bio (NYSE:NUVB) Insider Sells 150,000 Shares of Stock - MarketBeat
Why millennials buy Nuvation Bio Inc. Warrants stockJuly 2025 Summary & Risk Managed Investment Signals - Newser
Nuvation Bio (NUVB) Bounces Back 12% on Impressive Clinical Trial Result - Insider Monkey
Nuvation Bio (NYSE:NUVB) Stock Price Up 8.9%Still a Buy? - MarketBeat
NUVB SEC FilingsNuvation Bio Inc 10-K, 10-Q, 8-K Forms - Stock Titan
Nuvation Bio’s chief medical officer sells $1.17 million in stock By Investing.com - Investing.com South Africa
Nuvation Bio (NYSE:NUVB) Hits New 1-Year HighHere's What Happened - MarketBeat
Nuvation Bio Inc. (NYSE:NUVB) Given Consensus Recommendation of "Moderate Buy" by Analysts - MarketBeat
Will Nuvation Bio Inc. Class stock profit from AI boomJuly 2025 Selloffs & Trade Opportunity Analysis Reports - Newser
10 Stocks Stealing Market Spotlight - Insider Monkey
Nuvation Bio Announces Publication of Positive Phase 2 Study Results for Safusidenib for the Treatment of Grade 2 IDH1-Mutant Glioma in Neuro-Oncology - Investing News Network
Nuvation Bio’s Surge: Buy or Observe? - StocksToTrade
ETFs Investing in Nuvation Bio Inc. Stocks - TradingView
Nuvation Bio’s chief medical officer sells $1.17 million in stock - Investing.com
Nuvation Bio Insider Sold Shares Worth $1,173,255, According to a Recent SEC Filing - marketscreener.com
Nuvation Bio (NUVB) Chief Medical Officer reports 150K share sale and option exercise - Stock Titan
Nuvation Bio stock hits 52-week high at $8.24 - Investing.com
Nuvation Bio stock hits 52-week high at $8.24 By Investing.com - Investing.com Nigeria
NUVB: Iptrozi and Safusidenib show strong clinical and commercial momentum, driving major growth potential - TradingView
NUVB: Iptrozi and Safusidenib drive strong growth, with robust financials and pipeline innovation - TradingView
Nuvation Bio: Phase 2 study results in IDH1-mutant gliomas published - Traders Union
Will Nuvation Bio Inc. Warrants stock benefit from sector leadershipWeekly Loss Report & Real-Time Volume Analysis - Newser
Geode Capital Management LLC Acquires 864,194 Shares of Nuvation Bio Inc. $NUVB - MarketBeat
Will Nuvation Bio Inc. Class stock outperform benchmarks2025 Big Picture & Long-Term Growth Stock Strategies - Newser
Can Nuvation Bio Inc. Class stock surprise markets with earningsPortfolio Gains Summary & Stepwise Entry/Exit Trade Alerts - Newser
Is Nuvation Bio Inc. stock a safe buy before earningsTreasury Yields & AI Enhanced Market Trend Forecasts - Newser
Officer Liu Files To Sell 150,000 Of Nuvation Bio Inc [NUVB] - TradingView
H.C. Wainwright reiterates Buy rating on Nuvation Bio stock at $10 target By Investing.com - Investing.com South Africa
Nuvation Bio Inc (NUVB) 재무 분석
매출
순이익
현금흐름
주당 순 이익
1.08%
0.91%
자본화:
|
볼륨(24시간):